FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing a copolymer of sodium carboxy-methylcellulose and gossypol of formula (I) and use thereof in complex therapy of patients with autistic disorders and cognitive impairments, where a:b:c=1:(3-6):(5-7), n=40-50; molecular weight of 120000-130000.
EFFECT: high efficiency of treating mental illnesses.
11 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF RELIEVING RESISTANT DEPRESSIVE SYNDROMES OF PSYCHOSOMATIC CIRCLE | 2018 |
|
RU2696782C1 |
| AGENT FOR TREATING AND PREVENTING DISORDERS OF AUTISM SPECTRUM | 2015 |
|
RU2608444C1 |
| METHOD OF TREATMENT OF DUODENUM ULCER DISEASE COMPLICATED BY COMORBID ANXIOUS DEPRESSION DISORDERS | 2007 |
|
RU2357729C2 |
| CARBOXYMETHYLCELLULOSE COPOLYMER AND GOSSYPOL SODIUM SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR PROPHYLAXIS OR TREATMENT OF VIRAL DISEASE | 2004 |
|
RU2270708C1 |
| METHOD OF DETERMINING THE NECESSITY OF USING PSYCHO PHARMACOTHERAPY AMONG THE PATIENTS WITH DISORDERS OF AUTIST SPECTRUM AT THE MOMENT OF THEIR EXAMINATION | 2017 |
|
RU2643760C1 |
| AGENT FOR CORRECTING AUTISM SPECTRUM DISORDERS | 2017 |
|
RU2666598C1 |
| CONJUGATES OF GOSSYPOL AND SODIUM-CARBOXYMETHYL CELLULOSE, THEIR PRODUCTION METHODS AND ANTIVIRAL AGENTS ON THEIR BASIS | 2012 |
|
RU2499002C1 |
| COMBINATIONS OF COMPOUNDS MODULATING THE NMDA RECEPTOR | 2015 |
|
RU2721948C2 |
| THERAPEUTIC AGENTS | 2008 |
|
RU2468025C2 |
| APPLICATION OF MADOPAR FOR CORRECTION OF COGNITIVE, MOTIVATION, EMOTIONAL DISTURBANCES IN CHILDREN WITH AUTISTIC SPECTRUM DISORDERS | 2008 |
|
RU2403034C2 |
